Two new drugs finally hit ‘undruggable’ cancer target, providing hope for treatments By Jocelyn Kaiser Cancer researchers are making progress toward a goal that has eluded them for more than 30 years: shrinking tumors by shutting off a protein called KRAS that drives growth in many cancer types. A new type of drug aimed at KRAS … Continue reading Channing Der Interviewed by Science Magazine
Congratulations to Der Lab member, Clint Stalnecker, for winning first place in an oral research presentation competition at the 44th Annual Postdoc-Faculty Research Day! Read more about the 44th Annual Postdoc Faculty Research Day.
Kirsten Bryant, Ph.D., was one of three to be selected through a competitive process for this honor, which comes with a $2,500 award. The three recipients will be formally recognized in the ceremony and Kirsten will present. The Pagano Awards are named for Joseph Pagano, MD, UNC Lineberger director emeritus and Lineberger Professor of Cancer Research. … Continue reading Kirsten Bryant to Present at Pagano Award Ceremony
Kirsten Bryant, Ph.D., Research Assistant Professor in the Department of Pharmacology, was recently awarded a Developmental Research Project grant from the Washington University SPORE in Pancreatic Cancer. Congratulations, Kirsten!
July 13th, 2019 The Der and Cox labs met at Channing's home to wish lab members, Kat Lambert, Devon Blake, and Richard Hodge, well in their future careers. Kat was accepted to UNC-Chapel Hill for graduate school. Richard completed his post-doctoral fellowship and returned to England. Devon accepted a position at Ribometrix as a scientist. … Continue reading Lab Member Farewell Party
Channing Der is an expert in the field of so-called RAS genes, which play an important role regarding the control of cancer cell growth. The oncologist, who holds a professorship at the University of Carolina in Chapel Hill, continues his research at the Institute of Pathology at Charité-Universitätsmedizin Berlin. The aim of Der's research project … Continue reading Einstein BIH Visiting Fellow: Channing Der
June 20, 2019 UNC Lineberger presented three postdoctoral fellows with the Joseph S. Pagano Award to recognize their leadership of notable scientific publications. Kirsten Bryant, PhD, Ari Pani, PhD, and John Pryor, PhD, were selected through a competitive process for the honor, which comes with a $2,500 award. The three recipients will be formally recognized … Continue reading UNC Lineberger names Pagano Award recipients
New Der lab members, Jane Lee and Jonathan Deliberty will be giving talks today as new PHCO graduate students. At 11:30 am in 4007 GMB Jane will present on "Discovering novel therapies in combination with ERK inhibition in pancreatic cancer" while Jonathan will present "ERK and Autophagy Inhibition of Pancreatic Ductal Adenocarcinoma." Come out to support our … Continue reading Welcome New PHCO Students!
April 27, 2019 Last month, the Der Lab and UNC Lineberger friends participated for the sixth consecutive year in the annual PanCan Purplestide 5K. Together, the RAScals raised over $12,000, placing third in donations, and bringing them to a fundraising total of $69,180! Team Captain Kirsten Bryant was invited to open the event with a … Continue reading The UNC Running RAScals Race Again: PanCan Purplestride 2019
In this opinion piece in Nature Reviews Drug Discovery, Channing Der weighs in the “resurgence” in the interest in targeting autophagy for cancer treatment”. This resurgence has been fueled, in part, by Kirsten Bryant’s study published in Nature Medicine in April 2019. https://www.nature.com/articles/d41573-019-00072-1